Overview
Paul Armistead is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Armistead is rated as an Experienced provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant. Dr. Armistead is currently accepting new patients.
His clinical research consists of co-authoring 54 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
University Of North Carolina At Chapel Hill
Jonathan Serody is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Serody is rated as a Distinguished provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Serody is currently accepting new patients.
University Of North Carolina At Chapel Hill
William Wood is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Wood is rated as a Distinguished provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wood is currently accepting new patients.
Duke Adult Blood And Marrow Transplant Clinic
What makes Duke Health unique in bone marrow transplants is its holistic approach. We take care of the disease -- which is important, because these are very serious, potentially fatal diseases. But at the same time, we pay attention to patients’ emotional and psychological well-being in addition to their physical well-being. And not only for patients but also the whole family, because the caregivers and other parts of the family need attention as well. I wanted to go into medicine, because it was a great way to interact and take care of patients. In my mind, cancer is one of two diseases within internal medicine where you can actually cure people. The best part of bone marrow transplant is that the time between the laboratory and the patient is short. Patients who need a transplant tend to be relatively sick and in need of new therapies. That’s been very intellectually challenging and fun. Dr. Chao is rated as a Distinguished provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Multiple Myeloma, Bone Marrow Transplant, and Bone Graft.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without MaturationDr. Armistead isDistinguished. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Armistead isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Bone Marrow TransplantDr. Armistead isDistinguished. Learn about Bone Marrow Transplant.
- Multiple MyelomaDr. Armistead isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Armistead isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Childhood Acute Myeloid LeukemiaDr. Armistead isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- LeukemiaDr. Armistead isAdvanced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Dr. Armistead isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Myelomonocytic LeukemiaDr. Armistead isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult T-Cell LeukemiaDr. Armistead isExperienced. Learn about Adult T-Cell Leukemia.
- Aplastic AnemiaDr. Armistead isExperienced. Learn about Aplastic Anemia.
- Castleman DiseaseDr. Armistead isExperienced. Learn about Castleman Disease.
- Chronic B-Cell Leukemia (CBCL)Dr. Armistead isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Graft Versus Host Disease (cGvHD)Dr. Armistead isExperienced. Learn about Chronic Graft Versus Host Disease (cGvHD).